Incannex Healthcare IXHL
NASDAQ IXHL
$3.62 +0.18 (+5.23%)
As of: Aug 20, 2026 · 3:59 PM EDT

Incannex Healthcare (IXHL) Asset Utilization Ratio (2025)

Incannex Healthcare (IXHL) posted Asset Utilization Ratio of 0.0 for Q2 2025.

Incannex Healthcare (IXHL) Asset Utilization Ratio (2025) Analysis & Trends

Incannex Healthcare has reported Asset Utilization Ratio for 1 years, with the latest figure at 0.0 in Q2 2025.

  • Quarterly Asset Utilization Ratio changed N/A year-over-year to 0.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was 0.0 (changed N/A YoY) and the FY2025 annual result came in at 0.0, up 680.43% from the prior year.
  • Asset Utilization Ratio held at 0.0 in Q2 2025 per IXHL's latest filing.
  • Over five years, Asset Utilization Ratio peaked at 0.0 in Q2 2025 and troughed at 0.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn 0.43
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn 0.63
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn 0.47
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn 0.45
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn 0.41
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn 0.66
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn 0.37
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - -
10 Incannex Healthcare 43.22 Mn 43.22 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2025 0.00